These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 20530743)

  • 1. Induction of chimerism permits low-dose islet grafts in the liver or pancreas to reverse refractory autoimmune diabetes.
    Zhang C; Wang M; Racine JJ; Liu H; Lin CL; Nair I; Lau J; Cao YA; Todorov I; Atkinson M; Zeng D
    Diabetes; 2010 Sep; 59(9):2228-36. PubMed ID: 20530743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice.
    Guo Z; Wu T; Sozen H; Pan Y; Heuss N; Kalscheuer H; Sutherland DE; Blazar BR; Hering BJ
    Transplantation; 2003 Apr; 75(7):909-15. PubMed ID: 12698073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Subcutaneous Site of Islet Transplantation Superior to the Liver.
    Yasunami Y; Nakafusa Y; Nitta N; Nakamura M; Goto M; Ono J; Taniguchi M
    Transplantation; 2018 Jun; 102(6):945-952. PubMed ID: 29521877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy.
    Wu T; Levay-Young B; Heuss N; Sozen H; Kirchhof N; Sutherland DE; Hering B; Guo Z
    Transplantation; 2002 Jul; 74(1):22-7. PubMed ID: 12134094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice.
    Li H; Kaufman CL; Ildstad ST
    Surgery; 1995 Aug; 118(2):192-7; discussion 197-8. PubMed ID: 7638733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential outcomes in prediabetic vs. overtly diabetic NOD mice nonmyeloablatively conditioned with costimulatory blockade.
    Bozulic LD; Huang Y; Xu H; Wen Y; Ildstad ST
    Exp Hematol; 2011 Oct; 39(10):977-85. PubMed ID: 21726515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing donor chimerism and inducing tolerance to islet allografts by post-transplant donor lymphocyte infusion.
    Liu B; Hao J; Pan Y; Luo B; Westgard B; Heremans Y; Sutherland DE; Hering BJ; Guo Z
    Am J Transplant; 2006 May; 6(5 Pt 1):933-46. PubMed ID: 16611329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity.
    Nikolic B; Takeuchi Y; Leykin I; Fudaba Y; Smith RN; Sykes M
    Diabetes; 2004 Feb; 53(2):376-83. PubMed ID: 14747288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural crest stem cells increase beta cell proliferation and improve islet function in co-transplanted murine pancreatic islets.
    Olerud J; Kanaykina N; Vasylovska S; King D; Sandberg M; Jansson L; Kozlova EN
    Diabetologia; 2009 Dec; 52(12):2594-601. PubMed ID: 19823803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct requirements for achievement of allotolerance versus reversal of autoimmunity via nonmyeloablative mixed chimerism induction in NOD mice.
    Nikolic B; Onoe T; Takeuchi Y; Khalpey Z; Primo V; Leykin I; Smith RN; Sykes M
    Transplantation; 2010 Jan; 89(1):23-32. PubMed ID: 20061915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice.
    Abdulreda MH; Molano RD; Faleo G; Lopez-Cabezas M; Shishido A; Ulissi U; Fotino C; Hernandez LF; Tschiggfrie A; Aldrich VR; Tamayo-Garcia A; Bayer AS; Ricordi C; Caicedo A; Buchwald P; Pileggi A; Berggren PO
    Diabetologia; 2019 Jul; 62(7):1237-1250. PubMed ID: 31087105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined transplantation of pancreatic islets and adipose tissue-derived stem cells enhances the survival and insulin function of islet grafts in diabetic mice.
    Ohmura Y; Tanemura M; Kawaguchi N; Machida T; Tanida T; Deguchi T; Wada H; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Matsuura N; Ito T; Nagano H; Doki Y; Mori M
    Transplantation; 2010 Dec; 90(12):1366-73. PubMed ID: 21076379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet transplantation into brown adipose tissue can delay immune rejection.
    Kepple JD; Barra JM; Young ME; Hunter CS; Tse HM
    JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35015736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin gene transfer enhances the function of human islet grafts.
    Deng S; Vatamaniuk M; Lian MM; Doliba N; Wang J; Bell E; Wolf B; Raper S; Matschinsky FM; Markmann JF
    Diabetologia; 2003 Mar; 46(3):386-93. PubMed ID: 12687337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
    Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
    Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts.
    Li H; Colson YL; Ildstad ST
    Transplantation; 1995 Sep; 60(6):523-9. PubMed ID: 7570945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed chimerism and growth factors augment β cell regeneration and reverse late-stage type 1 diabetes.
    Wang M; Racine JJ; Song X; Li X; Nair I; Liu H; Avakian-Mansoorian A; Johnston HF; Liu C; Shen C; Atkinson M; Todorov I; Kandeel F; Forman S; Wilson B; Zeng D
    Sci Transl Med; 2012 May; 4(133):133ra59. PubMed ID: 22572882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.
    Lakey JR; Singh B; Warnock GL; Rajotte RV
    Transplantation; 1994 Apr; 57(8):1213-7. PubMed ID: 8178349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice.
    Smith DK; Korbutt GS; Suarez-Pinzon WL; Kao D; Rajotte RV; Elliott JF
    Transplantation; 1997 Oct; 64(7):1040-9. PubMed ID: 9381527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of an islet allograft deficient in iNOS after implantation into diabetic NOD mice.
    Börjesson A; Andersson AK; Sandler S
    Cell Transplant; 2006; 15(8-9):769-75. PubMed ID: 17269447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.